Anterogen.Co.Ltd Balance Sheet Health
Financial Health criteria checks 6/6
Anterogen.Co.Ltd has a total shareholder equity of ₩114.7B and total debt of ₩0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are ₩121.1B and ₩6.4B respectively.
Key information
0%
Debt to equity ratio
₩0
Debt
| Interest coverage ratio | n/a |
| Cash | ₩40.25b |
| Equity | ₩114.69b |
| Total liabilities | ₩6.40b |
| Total assets | ₩121.09b |
Financial Position Analysis
Short Term Liabilities: A065660's short term assets (₩46.1B) exceed its short term liabilities (₩924.9M).
Long Term Liabilities: A065660's short term assets (₩46.1B) exceed its long term liabilities (₩5.5B).
Debt to Equity History and Analysis
Debt Level: A065660 is debt free.
Reducing Debt: A065660 has no debt compared to 5 years ago when its debt to equity ratio was 68.6%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: A065660 has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: A065660 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 7.4% each year